Vasopressin V1b Receptor Market Report

Global Vasopressin V1b Receptor Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • POSTDATE：Jun 07, 2022
  • PAGES：142
  • REPORT CODE：GMM830001
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Vasopressin V1b Receptor market report explains the definition, types, applications, major countries, and major players of the Vasopressin V1b Receptor market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Allergan Plc

    • Orphan Therapeutics, LLC

    • Azevan Pharmaceuticals Inc

    • Laboratorio ELEA SACIF y A

    • AbbVie Inc

    By Type:

    • PHT-103

    • ABT-436

    • AVN-628

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Vasopressin V1b Receptor Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Vasopressin V1b Receptor Outlook to 2028- Original Forecasts

    • 2.2 Vasopressin V1b Receptor Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Vasopressin V1b Receptor Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Vasopressin V1b Receptor Market- Recent Developments

    • 6.1 Vasopressin V1b Receptor Market News and Developments

    • 6.2 Vasopressin V1b Receptor Market Deals Landscape

    7 Vasopressin V1b Receptor Raw Materials and Cost Structure Analysis

    • 7.1 Vasopressin V1b Receptor Key Raw Materials

    • 7.2 Vasopressin V1b Receptor Price Trend of Key Raw Materials

    • 7.3 Vasopressin V1b Receptor Key Suppliers of Raw Materials

    • 7.4 Vasopressin V1b Receptor Market Concentration Rate of Raw Materials

    • 7.5 Vasopressin V1b Receptor Cost Structure Analysis

      • 7.5.1 Vasopressin V1b Receptor Raw Materials Analysis

      • 7.5.2 Vasopressin V1b Receptor Labor Cost Analysis

      • 7.5.3 Vasopressin V1b Receptor Manufacturing Expenses Analysis

    8 Global Vasopressin V1b Receptor Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Vasopressin V1b Receptor Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Vasopressin V1b Receptor Export by Region (Top 10 Countries) (2017-2028)

    9 Global Vasopressin V1b Receptor Market Outlook by Types and Applications to 2022

    • 9.1 Global Vasopressin V1b Receptor Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global PHT-103 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global ABT-436 Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global AVN-628 Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Vasopressin V1b Receptor Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinic Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Vasopressin V1b Receptor Market Analysis and Outlook till 2022

    • 10.1 Global Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.2.2 Canada Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.2.3 Mexico Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.2 UK Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.3 Spain Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.4 Belgium Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.5 France Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.6 Italy Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.7 Denmark Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.8 Finland Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.9 Norway Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.10 Sweden Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.11 Poland Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.12 Russia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.3.13 Turkey Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.2 Japan Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.3 India Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.4 South Korea Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.5 Pakistan Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.6 Bangladesh Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.7 Indonesia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.8 Thailand Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.9 Singapore Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.10 Malaysia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.11 Philippines Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.4.12 Vietnam Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.2 Colombia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.3 Chile Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.4 Argentina Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.5 Venezuela Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.6 Peru Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.7 Puerto Rico Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.5.8 Ecuador Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.6.2 Kuwait Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.6.3 Oman Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.6.4 Qatar Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.7.2 South Africa Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.7.3 Egypt Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.7.4 Algeria Vasopressin V1b Receptor Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Vasopressin V1b Receptor Consumption (2017-2022)

      • 10.8.2 New Zealand Vasopressin V1b Receptor Consumption (2017-2022)

    11 Global Vasopressin V1b Receptor Competitive Analysis

    • 11.1 Allergan Plc

      • 11.1.1 Allergan Plc Company Details

      • 11.1.2 Allergan Plc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Allergan Plc Vasopressin V1b Receptor Main Business and Markets Served

      • 11.1.4 Allergan Plc Vasopressin V1b Receptor Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Orphan Therapeutics, LLC

      • 11.2.1 Orphan Therapeutics, LLC Company Details

      • 11.2.2 Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Orphan Therapeutics, LLC Vasopressin V1b Receptor Main Business and Markets Served

      • 11.2.4 Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Azevan Pharmaceuticals Inc

      • 11.3.1 Azevan Pharmaceuticals Inc Company Details

      • 11.3.2 Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Main Business and Markets Served

      • 11.3.4 Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Laboratorio ELEA SACIF y A

      • 11.4.1 Laboratorio ELEA SACIF y A Company Details

      • 11.4.2 Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Main Business and Markets Served

      • 11.4.4 Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 AbbVie Inc

      • 11.5.1 AbbVie Inc Company Details

      • 11.5.2 AbbVie Inc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 AbbVie Inc Vasopressin V1b Receptor Main Business and Markets Served

      • 11.5.4 AbbVie Inc Vasopressin V1b Receptor Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    12 Global Vasopressin V1b Receptor Market Outlook by Types and Applications to 2028

    • 12.1 Global Vasopressin V1b Receptor Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global PHT-103 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global AVN-628 Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Vasopressin V1b Receptor Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Clinic Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Vasopressin V1b Receptor Market Analysis and Outlook to 2028

    • 13.1 Global Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.2.2 Canada Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.2 UK Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.3 Spain Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.5 France Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.6 Italy Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.8 Finland Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.9 Norway Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.11 Poland Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.12 Russia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.2 Japan Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.3 India Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.3 Chile Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.6 Peru Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.6.3 Oman Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Vasopressin V1b Receptor Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Vasopressin V1b Receptor Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Vasopressin V1b Receptor

    • Figure of Vasopressin V1b Receptor Picture

    • Table Global Vasopressin V1b Receptor Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Vasopressin V1b Receptor Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global PHT-103 Consumption and Growth Rate (2017-2022)

    • Figure Global ABT-436 Consumption and Growth Rate (2017-2022)

    • Figure Global AVN-628 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Hospital Consumption and Growth Rate (2017-2022)

    • Figure Global Clinic Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Table North America Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure United States Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Canada Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Mexico Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table Europe Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure Germany Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure UK Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Spain Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Belgium Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure France Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Italy Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Denmark Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Finland Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Norway Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Sweden Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Poland Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Russia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Turkey Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table APAC Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure China Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Japan Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure India Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Korea Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Thailand Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Singapore Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Philippines Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table South America Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure Brazil Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Colombia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Chile Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Argentina Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Peru Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table GCC Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure Bahrain Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Oman Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Qatar Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table Africa Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure Nigeria Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure South Africa Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Egypt Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure Algeria Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table Oceania Vasopressin V1b Receptor Consumption by Country (2017-2022)

    • Figure Australia Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Vasopressin V1b Receptor Consumption and Growth Rate (2017-2022)

    • Table Allergan Plc Company Details

    • Table Allergan Plc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Allergan Plc Vasopressin V1b Receptor Main Business and Markets Served

    • Table Allergan Plc Vasopressin V1b Receptor Product Portfolio

    • Table Orphan Therapeutics, LLC Company Details

    • Table Orphan Therapeutics, LLC Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orphan Therapeutics, LLC Vasopressin V1b Receptor Main Business and Markets Served

    • Table Orphan Therapeutics, LLC Vasopressin V1b Receptor Product Portfolio

    • Table Azevan Pharmaceuticals Inc Company Details

    • Table Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Main Business and Markets Served

    • Table Azevan Pharmaceuticals Inc Vasopressin V1b Receptor Product Portfolio

    • Table Laboratorio ELEA SACIF y A Company Details

    • Table Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Main Business and Markets Served

    • Table Laboratorio ELEA SACIF y A Vasopressin V1b Receptor Product Portfolio

    • Table AbbVie Inc Company Details

    • Table AbbVie Inc Vasopressin V1b Receptor Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Vasopressin V1b Receptor Main Business and Markets Served

    • Table AbbVie Inc Vasopressin V1b Receptor Product Portfolio

    • Figure Global PHT-103 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global ABT-436 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global AVN-628 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Table North America Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure United States Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure Germany Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure China Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure Brazil Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Vasopressin V1b Receptor Consumption Forecast by Country (2022-2028)

    • Figure Australia Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Vasopressin V1b Receptor Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US